# Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)

> **NCT00408278** · PHASE4 · COMPLETED · sponsor: **PETHEMA Foundation** · enrollment: 300 (estimated)

## Conditions studied

- Acute Promyelocytic Leukemia

## Interventions

- **DRUG:** ATRA
- **DRUG:** Idarubicina
- **DRUG:** Mitoxantrone
- **DRUG:** ARA-C

## Key facts

- **NCT ID:** NCT00408278
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2012-04
- **Final completion:** 2013-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2014-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00408278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00408278, "Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00408278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*